Background: Tramadol binds to opioid receptors and inhibits norepinephrine and serotonin reuptake, causing serotonin syndrome. Tianeptine stimulates serotonin reuptake and reduces serotonin levels. The aim of this study was to investigate whether tianeptine is effective against serotonin syndrome that may occur with serotoninergic drugs such as tramadol and citalopram. Methods: Rats were divided into eight groups (n = 6) that received tramadol (50 mg/kg), citalopram (10 mg/kg), or tianeptine (5 mg/kg) alone or a combination of tramadol + citalopram, tramadol + tianeptine, citalopram + tianeptine or tramadol + citalopram + tianeptine at the same doses administered to the stomach by oral gavage for 3 weeks. The healthy control group was given saline. Malondialdehyde, total glutathione, superoxide dismutase, and catalase levels were measured in removed brain tissues. The tissues were also examined histopathologically. Results: In the tramadol, tramadol + citalopram, and tramadol + citalopram + tianeptine groups, malondialdehyde levels were found to be higher compared to the control group, while glutathione, superoxide dismutase, and catalase levels were found to be lower. In other groups, values close to the control group were measured. Morphological degeneration was observed in neurons in the tramadol + citalopram group. The swelling of astrocytes and pericellular edema in oligodendrocytes were also observed. A significant population increase was noted in microglial cells. Blood vessels belonging to the tissue were observed to be severely dilated and congested. Histopathological damage was partially resolved in the group given tramadol + citalopram + tianeptine. Conclusions: The tramadol + citalopram combination caused severe oxidative stress in brain tissue. Tramadol alone caused mild damage in brain tissue, whereas tianeptine prevented the brain damage caused by tramadol.
Objectives: Delayed gastric emptying create a risk of pulmonary aspiration during anesthesia. We aim to assess the antral cross-sectional area (CSA) and gastric volume using ultrasound techniques and to investigate the relationship between these variables and both the duration and regulation of type 2 diabetes mellitus (DM). Methods: Gastric volume was estimated by measuring the antral CSA in the supine and right lateral decubitus (RLD) positions in 80 patients. The antral content was qualitatively classified according to Perlas et al. (grades 0, 1, and 2), and gastric volume was computed using a previously described formula. The presence of solid content or > 1.5 mL/kg fluid in the stomach was classified as indicative of a full stomach. Results: The mean duration of diabetes among the subjects was 9.4 ± 3.7 years. The mean fasting duration was 10.2 ± 2.1 hours for solids and 2.5 ± 0.7 for liquids. Twelve of the 80 patients exhibited grade 2 stomach. Age (p = 0.005), Body mass index (p = 0.001), solid fasting duration (p = 0.027), and supine and RLD CSA (p < 0.001 for both) were significantly associated with full stomach. A history of ≥8 years of diabetes (p < 0.001) and peripheral neuropathy (p = 0.005) was identified as a risk factor for a full stomach. Conclusions: Despite adherence to standard fasting protocols, 15% of the type 2 DM patients were identified with a 'full stomach' condition. Preoperative ultrasound assessment of gastric contents in patients with type 2 DM, especially with long-standing diabetes (≥ 8 years) and with peripheral neuropathy is recommended. The findings of this study necessitate additional investigation to support the conceptualization of specific guidelines for diabetes to mitigate the risk of pulmonary aspiration.
Background: Prolonged extubation and pain following cardiac surgery remain significant clinical challenges. The pecto-intercostal fascial plane block (PIFB) is an emerging regional anesthesia technique incorporated into multimodal analgesia protocols to reduce opioid consumption and facilitate early extubation. This study retrospectively evaluated extubation times, perioperative opioid consumption, and postoperative analgesic requirements in patients who underwent isolated open-heart surgery via median sternotomy, comparing those who received PIFB with those who did not. Methods: This retrospective single-center study included ninety-nine patients who underwent isolated on-pump coronary artery bypass graft surgery via median sternotomy between 1 June 2023 and 25 March 2024. The study included 46 patients who received PIFB (Group 1) and 53 patients who received no block (Group 2). Ultrasound-guided bilateral PIFB was performed after anesthesia induction, with a total of 40 mL administered to each side (30 mL 0.25% bupivacaine + 10 mL normal saline). Demographic data, perioperative data, extubation times, analgesic consumption, and complications were compared between groups. Results: Demographic data, EuroSCORE, body mass index, and ejection fraction were similar between groups. Perioperative opioid (fentanyl) consumption was statistically significantly higher in Group 2 (median 450 [IQR: 350–600] μg vs. 400 [IQR: 350–450] μg; p = 0.037). Extubation time was statistically significantly shorter in Group 1 compared to Group 2 (median 340 [IQR: 265–490] min vs. 495 [IQR: 420–555] min; p < 0.001). The number of patients requiring postoperative paracetamol and tramadol was statistically significantly lower in Group 1 (p = 0.015 and p < 0.001, respectively). No statistically significant difference was found between groups regarding chest drain removal, length of hospital stay, or ICU length of stay (p > 0.05). Mortality occurred in 1 patient in Group 1 and 2 patients in Group 2. Conclusions: PIFB application in isolated open-heart surgery performed via median sternotomy was associated with shorter extubation time and reduced perioperative fentanyl and postoperative analgesic consumption, without a statistically significant effect on hospital length of stay. Complication and mortality data are reported descriptively; the study does not have sufficient statistical power to draw inferences regarding safety outcomes.
Objectives: Tranexamic acid significantly reduces postoperative bleeding and transfusion requirements in cardiac surgery. Intravenous administration has been associated with thromboembolism and seizures. The complex protocols and serious side effects associated with this administration increase interest in intrapericardial administration, and its preferability is being reviewed. The purpose of this prospective, randomized, double-blind study was to compare the effects of intrapericardial tranexamic acid administered following cardiac surgery with those of intravenous administration on postoperative bleeding and possible complications. Methods: The study included 60 patients over the age of 18 who were undergoing elective coronary artery bypass grafting for the first time. The patients were randomized into intravenous and intrapericardial groups. Primary postoperative bleeding and transfusion requirements, and secondarily complications, reoperation and discharge times were evaluated. Results: The 60 coronary artery bypass grafting patients included in the study, consisting of 30 patients in intravenous and intrapericardial groups, were not different from each other in terms of demographic data and Euroscore parameters. Postoperative 24-hour chest tube drainage was measured as 890±551 mL in the intrapericardial group and 708±504 mL in the intravenous group. The similar drainage amounts detected in the two groups did not create a statistically significant difference (P=0.190). Transfusion requirements were similar in both groups. No complications developed in any patient and no reoperation was required due to bleeding. Conclusions: In conclusion; intrapericardial tranexamic acid application in coronary artery bypass grafting surgery reduces postoperative bleeding and transfusion requirement at an equivalent rate to intravenous. Intrapericardial application, which can provide the same effect without creating extra risk, may be a simpler and more practical method than systemic application, which includes complex protocols regarding dose and timing.
Background and Objectives: Screw cut-out is the most common mechanical complication after intertrochanteric fracture fixation with proximal femoral nails (PFNs). While the traditional tip–apex distance (TAD) is widely used, the calcar-referenced TAD (CalTAD) may better represent inferomedial cortical support. This study aimed to identify radiographic predictors of cut-out in dual-screw PFN fixations and establish a clinically relevant threshold for inferior-screw-based CalTAD. Materials and Methods: A retrospective cohort of patients treated with a dual cephalic screw PFN between 2017 and 2024 was analyzed. The implant uses two equal-diameter screws. Radiographic parameters included TAD, inferior-screw CalTAD, reduction quality, lateral wall thickness (LWT), collodiaphyseal angle (CDA), and Cleveland zone positioning. Logistic regression analyses were used to identify independent predictors of mechanical failure. Results: Both TAD and CalTAD values were significantly higher in patients who experienced screw cut-out. ROC analysis identified an inferior-screw-referenced CalTAD cutoff with strong predictive accuracy (AUC = 0.84). Optimal screw positioning, particularly avoiding superior placement on AP radiographs, was associated with reduced cut-out risk, while anterior positioning on the lateral view demonstrated only a borderline effect. Reduction quality showed borderline significance in univariate testing but remained independently predictive in multivariate modeling, while LWT and CDA were not significantly different between groups. Conclusions: Ensuring the inferior lag screw is positioned close to the calcar and achieving a low CalTAD, together with proper Cleveland zone alignment, appear to be key technical goals for minimizing mechanical cut-out in dual-screw PFN fixations. These findings support the use of inferior-screw–referenced CalTAD as a reliable and reproducible parameter for surgical optimization.
Background: Whether chewing gum or candy consumption during preoperative fasting affects aspiration risk remains debated. This study investigated the effects of these products on gastric volume and pH, and evaluated procedure difficulty, satisfaction, and fasting-related symptoms. Methods: This randomized, double-blind study enrolled 405 patients scheduled for elective gastroscopy, equally allocated to control, chewing gum, and candy groups. All groups adhered to standard fasting protocols; the chewing gum and candy groups additionally consumed the assigned products within 2 hours of sedation induction. Gastric contents were aspirated and analyzed for volume and pH. Fasting-related symptoms and satisfaction were assessed prior to discharge using a 3-point Likert scale. Results: Baseline characteristics were comparable across groups. Fasting duration was significantly shorter in the chewing gum group ( P = .030). Gastric volume was significantly higher in both intervention groups than in the control group ( P < .001); however, all values remained below the aspiration threshold of 0.5 mL/kg with small effect sizes. No significant between-group differences in gastric pH were observed ( P = .697). Procedure difficulty, satisfaction, and complication rates did not differ across groups. Chewing gum reduced thirst while increasing hunger, whereas candy reduced hunger while increasing thirst (all P < .001). Conclusion: Preoperative chewing gum or candy consumption produced a statistically significant but clinically negligible increase in gastric volume without affecting gastric pH. The distinct effects on fasting-related symptoms suggest that symptom-based product selection may improve patient comfort. These findings indicate that preoperative chewing gum or candy intake does not meaningfully increase the risk of aspiration before endoscopic procedures.